
Jim Cramer Discusses Various Stock Market Insights and Company Valuations
Jim Cramer has offered diverse insights on the stock market, including his reluctance to recommend Pfizer despite its dividend, defending a struggling tech giant, and highlighting future earnings projections for Oracle and Meta's entry into the neocloud business.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)Sources
Cramer defends a struggling tech giant and says another stock could soon be a buy
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Read full article →‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend
Read full article →Coverage Timeline
Related Stories

Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now

Hacker behind Latvian State Forests attack also active in Romania; Cert.lv assists investigation
just now

Contemporary Dance Performance 'Sugmija' Explores AI and Love in Riga
6m ago
Philadelphia Eagles Coach Nick Sirianni Utilizes AI for 2026 Season Preparation
31m ago